TGM2 and celiac disease: This indicates that TG2 is prone to rapid proteolytic degradation in the mouse gut lumen, but given that celiac disease antibodies detect conformational epitopes of TG2,1 it is conceivable that B cells in gut-associated lymphoid tissue can bind the structurally intact enzyme.